Artificial Intelligence in Healthcare Market Analysis, Future Plans, Technological Advancement

This Market report “Global Healthcare Artificial Intelligence Market Research Report By 2023” provides detailed insight covering all important parameters including Development Trends, Challenges, Opportunities, Key Manufacturers and Competitive Analysis.

Healthcare Artificial Intelligence Market Synopsis

Market Research Future (MRFR) asserts that the global Artificial Intelligence in Healthcare market size is estimated to demonstrate 51.9% CAGR during the forecast period (2018-2023). Rising application of AI in the field of drug discovery is favoring the market growth to a large extent. Artificial intelligence (AI) is referred to as the engineering and science which is adopted to design intelligent machines like intelligent computer programs. It is a system which applies several human intelligence-based functions like learning, reasoning, and problem-solving skills on disciplines like computer science, biology, linguistics, mathematics, and engineering. Artificial intelligence is considered the next frontier for healthcare innovation. AI in healthcare is implemented for sorting both structured and unstructured data. Fields of healthcare like oncology, neurology, and cardiology are experiencing a growing application of AI.

Read more news on:

Healthcare Artificial Intelligence Market Competitive Dashboard

The prominent players operating the Artificial Intelligence in Healthcare market are Koninklijke Philips N.V., IBM Watson Health, NVIDIA Corporation, CloudMedx Inc., Microsoft Corporation, Google, General Electric, Next IT Corp., Intel Corporation, DEEP GENOMICS, General Vision, and Stryker.

Healthcare Artificial Intelligence Market Potential and Pitfalls

Artificial Intelligence has developed several applications in the healthcare sector, such as delivery of health services, detection of diseases, drug discovery, and management of chronic diseases. It ensures effectiveness and efficiency which is likely to trigger its adoption rate in the coming years. AI has also strengthened its foothold in the healthcare research sector for delivering accurate results. This has further contributed to the growth of the market throughout the estimated period. The technology also helps to overcome the human resource crisis by providing increased productivity by automation of complicated tasks. With the increased application of AI in the field of the medical imaging industry, drug discovery, genomics, and precision medicine combined with the rising personalized treatments customized according to the requirements of an individual patient, the global Artificial Intelligence in Healthcare market is estimated to flourish.

The demand for artificial intelligence in order to perform data mining and trigger the speed of healthcare delivery services has increased. Moreover, the advent of novel and promising applications for diagnosing and monitoring the disease is predicted to contribute to the market growth throughout the assessment period. Advancements made in the data analytics will further propel the Artificial Intelligence in Healthcare market in the coming years. With a massive amount of data being generated every year in the healthcare sector coupled with the ever-increasing volume of big data has created the need to adapt AI so that data can be managed effectively. The AI research team of Google has recently launched its Google Deepmind Health project for data mining of medical records in order to offer better and faster services.

On the contrary, strict mandates regulating AI and high cost associated with its implementation are anticipated to slowdown the market growth throughout the assessment period. Moreover, the reluctance among the healthcare professionals and an imprecise regulatory scenario in order to adopt such technologies are presumed to hinder the market growth in the coming years.

Global Artificial Intelligence in Healthcare Market: Segmental Analysis

The global Artificial Intelligence in Healthcare Market Report has been segmented on the basis of component, application, technology, and end-users.

By mode of component, the healthcare AI market has been segmented into software, hardware, and services.

By mode of application, the healthcare AI market has been segmented into virtual nursing assistant, robot-assisted surgery, clinical trial, dosage error reduction, automated image diagnosis, and preliminary diagnosis. Among these, the robot-assisted surgery is predicted to occupy a significant share owing to the high flexibility and precision ensured by robot-assisted surgeries during performing complicated procedures.

By mode of technology, the healthcare AI market has been segmented into querying method, machine learning, and natural language processing. Among these, the machine-learning segment is predicted to experience the highest CAGR owing to the ability to handle multiple dimensional data while enabling a reduction in the process time cycle.

By mode of end-users, the global Artificial Intelligence in Healthcare market has been segmented into pharmaceutical & biotechnology companies, hospital & diagnostic centers, and academic & research laboratories. Among these, the hospitals & diagnostic centers occupy the largest market share owing to the extensive application of AI in diagnostic imaging and robotic surgeries.

Healthcare Artificial Intelligence Market Regional Insights

Geographically, the Artificial Intelligence in Healthcare market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Among all the regions, the American region is estimated to dominate the AI in the healthcare market and is likely to retain its dominance in the coming years. The growth in this region is credited to the growth witnessed in the biotechnology sector. Moreover, the augmenting cases of robotics surgeries coupled with the presence of a well-developed healthcare sector are contributing to the growth of the market in this region.

The European region has secured the second position and is estimated to garner USD 3453.4 million during the appraisal period. The factors catalyzing the proliferation of the market are the extensive R&D made for healthcare AI combined with the rising funding.

Meanwhile, the Asia Pacific region is likely to register 52.4% CAGR in the coming years owing to the increased therapeutic demand for chronic diseases. Also, the fast-developing healthcare sector is influencing the market growth to a large extent.

Healthcare Artificial Intelligence Industry Updates

February 21, 2019: A team of scientists from the University of California and the University of Surrey has together used AI network in order to identify and scrutinize the symptoms in patients suffering from cancer. The new study elaborates how researchers have used network analysis in order to examine the relationship and structure between 38 common symptoms reported by the cancer patients receiving chemotherapy.

Obtain Premium Research Report Details considering the impact of COVID-19 @

Radiology Information System (RIS) Market Trends, Industry Forecast, Applications, Growth Drivers, Trends, Demands – Global Forecast To 2023

Global Radiology Information System (RIS) Market Report by MRFR stretches out accurate and descriptive details through the range of years 2018-2023. This Industry report comprises interior and outside exploration and bits of comprehension of Radiology Information System (RIS) Market.

Radiology Information System (RIS) Market Overview:

Radiology Information System (RIS) Market is drifting towards an unprecedented market valuation with a growth that is almost double of its 2017 valuation. The technology has stirred a lot of feathers in recent times with its revolutionary impact in the healthcare sector. Its impact can be felt in the imaging technology mostly where the physicians now mostly rely on the radiology imaging as its accuracy is better than the rest available in the market. The workflow has become much smoother in the radiology units due to the advents in a radiology information system. Integration of computer has further helped in sharing reports and better coordination which eases the process of diagnosis or treatments. The global radiology information system market size can expect a rise up to USD 1100 million with an impressive 8.20% CAGR during the forecast period (2018-2023). Market Research Future’s (MRFR’s) report on the same provides some insights on the segmental analysis and drivers that can veer the radiology information system market towards better prospect.

Read more News on :

Cloud technology is expected to take the radiology information system market growth further ahead in the coming years. The system requires bulk data storage which can work offline as well. Cloud provides easy sharing and storage of bulk data. At the same time, non-invasive diagnostic and curative means are getting traction due to which the radiology information system can experience much preference in the healthcare sector. Escalating investment in the healthcare sector can open up avenues for the radiology information system market which can lead to better prospects in the coming years.

However, risks are also several as storing information on a cloud platform can attract the attention of the online hackers. A data breach can make individuals vulnerable to potential threats. This can prove to be a significant irritant for the radiology information system market.

Radiology Information System (RIS) Market Segmentation:

Radiology information system industry analysis can be segmented by component, type, end-user, deployment, and region.

Deployment-based segmentation of the radiology information system market consists of on-premise and cloud-based/web-based.

Type-wise segmentation of the radiology information system market comprises standalone radiology information system and integrated radiology information system.

Based on the end-users, the radiology information system market can be segmented into research & academic institutes, hospitals & clinics and others.

Component-wise segmentation of the radiology information system market consists services, software, and hardware.

Radiology Information System (RIS) Market Regional Segmentation:

Region-specific analysis of the radiology information system market includes namely Asia Pacific (APAC), the Americas, the Middle East & Africa (MEA) and Europe.

The Americas is driving the market forward at present. The trend is expected to remain the same during the forecast period. This can be attributed to the cost-effectiveness of EHRs, technological advancement level, rising investment in the healthcare sector and increasing adoption of cloud computing and web-based solutions to facilitate procedures & simplify workload.

Europe and the APAC can become profitable growth pockets for the radiology information system market. The regions together control almost a 74.8 % share of the global market. The APAC region is enjoying the bliss of countries investing much in the healthcare sector to evolve as a possible medical tourism hub. Pharmaceutical companies are also eyeing for expansion in the region as it offers business prospects with minimal investment.

Radiology Information System (RIS) Market Competitive Analysis:

Companies making a name for themselves in the radiology information system indusrty are IMAGE information systems, Ambra health, Advanced data systems corporation, Carestream Health, eRAD, Epic systems, PERFECT Imaging, LLC, IBM Watson health, Allscripts healthcare solutions, Cerner Corporation, Medinformatix, Inc, Bayer AG, Koninklijke Philips N.V, GE healthcare, and NextGen Healthcare.

Browse Complete Report with TOC at

Radiology Information System (RIS) Industry News

In 2018, Philips unveiled their latest IntelliSpace Discovery 3.0 that is a comprehensive, open platform where Artificial Intelligence gains prominence in radiology, and it enables radiologists to aggregate, normalize and anonymize data. This data can later be analyzed with algorithms.

In November 2018, QT Ultrasound launched eRAD RIS and PACS that can be considered the best possible breast imaging system with high-resolution transmission ultrasound images, without compression or radiation.

Mental Health Software and Devices Market 2020 Size, Share, Industry Trends, Business Revenue And Forecast Statistics

The Industry report for “Mental Health Software and Devices Market” by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the industry performance.

Mental Health Software and Devices Market Competition Outlook

Prominent mental health software vendors and device manufacturers profiled in the report include Athena Health, Mindlinc, Mentegram, WRS Health, Kareo, Nextgen Healthcare, ICANotes, Core Solutions, InSync Healthcare Solutions, Compulink, Allscripts, Nuesoft Technologies, NextStep Solutions, Valant, Credible Behavioral Health, Welligent, Raintree Systems, Netsmart, Meditab Software, Orion Health, The Echo Group, Sigmund Software, IBM, TheraNest, Advanced Data Systems, AdvancedMD, Qualifacts, McKesson Corporation, iSalus Healthcare, and Cerner Corporation.

Read more news on:

Mental Health Software and Devices Market Outlook

Mental health has come into focus due to changing lifestyles of patients and unhealthy work hours. Mental health software and devices utilizes the power of information technology to keep a check on mental or behavioral disorders. The global mental health software and devices market report by Market Research Future (MRFR) focuses on various issues plaguing the Mental health market as well as efforts by manufacturers.

The global mental health software and devices market size can expand from 2017 to 2023 (forecast period) due to the rapid adoption of software by mental health professionals. Change in health practices due to availability of patient records and mental health history can lead to effective management of patients. Collection and analysis of information, elimination of errors, rise in patient income levels, and demand for effective solutions for management of mental health are other drivers of the market.

Development of wearables, changing attitudes of patients and doctors

 towards information technology, and pressure on hospitals to reduce operational costs can drive the global mental health software and devices market. Real-time monitoring of patient health and provision of advice and medicines via telemedicine can bode well for the market growth in the coming years.

Paucity of skilled personnel, limited insurance coverage costs, and concerns over digital information are challenges faced by the market.

Mental Health Software and Devices Market Segmentation Analysis

the global mental health software and devices market size is segmented on the basis of solution, deployment, end users and regions.

By component, the market has been segmented by software and devices. The software has been sub-segmented into web based and standalone software.

By functionality, the market has been segmented by clinical, administrative, financial and others. The clinical segment has been categorized into tele-health, electronic health records (EHRs), E-prescribing, clinical decision support, health management, and others. The administrative has been sub segmented into information management, scheduling, workforce management, and others.

The financial has been sub segmented into accounting, revenue cycle management, business intelligence, and others.

By end user, the market has been segmented by providers, payers, and patients.

Mental Health Software and Devices Market Regional Analysis

Region-wise, the global market comprises North America, Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.

North America accounted for the largest market led by the U.S. due to focus on mental health by governments. According to the American Psychological Association in 2019, the number of young U.S. citizens with an increase of mental health disorders has risen due to shift in mood disorders. Other drivers include rapid adoption of technology and development of healthcare infrastructure by governments.

Europe is the second largest region of the market driven by large number of burnout cases and mental health issues of employees. Governments in the region have developed a common platform for collection of mental health issues and records of patients for implementation of good policies as well as welfare schemes. On the other hand, the APAC region is expected to exhibit the fastest growth rate during the forecast period due to being driven by economies of China, India, and Japan. International brands in the region are giving mental health insurance for preventing burnouts and reducing stress in the workplace.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Mental Health Software and Devices Industry News

Mental health software providers are currently rolling out a suite of products to lower the stress on non-core functions allowing physicians to focus on patients. Governments are launching websites dedicated to mental health for making it convenient for patients to reach out to doctors in cases of extreme stress.

Agricultural Biotechnology Market Latest Innovations, Analysis, Business Opportunities, Industry Revenue And Forecast

A Broad Analysis of the “Worldwide Agricultural Biotechnology Market “methodology of the leading organizations in the exactness of Import/Export Utilization, Industry Activity Figures, Cost, Value, Revenue and Gross Edges.

Agricultural Biotechnology Market Overview

The international agricultural biotechnology market is speculated to witness growth at CAGR of 10.10% by 2022. It was estimated to be worth USD 27,778.64 Million in 2018. Agricultural biotechnology market is considered as one of the swiftly advancing segments due to growing cultivation of biotechnology-based products. The growing level of investment in research and development is also touted as among the prime reasons behind the significant prospect of the market all throughout. With growing entrepreneurial emphasis, the market is speculated to advance in a much effective fashion.     

Read more news on:

Demand for agricultural biotechnology is witnessing consistent growth. This can be realized through the growing level of cultivation of the biotech crops. Moreover, cultivation has grown all across the globe. In fact, this aspect is speculated to enhance the growth of the international agricultural biotechnology market. It can be seen the level of demand for genetically modified crops has grown in a great way. Especially, the growth has been witnessed in developed parts like Europe.

The international zone for the biotechnology crops was around 190 million hectares, which was 185 million in 2016. In short, the level of cultivation is steadily growing and is expected to remain constant during the forecast period. The amount of land acquired and used for these purposes has grown in all parts, including the US. Above all, more than 70 nations have accepted the biotech crop cultivation. To be specific, India, US, Brazil, Argentina, and Canada are among the leading names in this context.   

Agricultural Biotechnology Market Segmentation

International Agricultural Biotechnology Market Size can be segmented on the basis of crop Type, Application, And Technique. On the basis of crop type, the global agricultural biotech market can be segmented into soybean, maize, cotton, and others. On the basis of application, the international agricultural biotechnology market is segmented into herbicide tolerance, stacked traits, insect tolerance, and others. In terms of technique, the international agricultural biotechnology is divided into genetic engineering, molecular breeding, molecular diagnostics, and tissue culture. Similarly, the market is segmented on the basis of region as well, is divided into the US, Europe, Asia Pacific, Middle East, and Africa. 

Agricultural Biotechnology Market Regional Analysis

On the basis of region, the international agricultural biotech market is segmented into the US, Europe, Asia-Pacific, Middle East, and Africa. The US is considered the global leader in the agricultural biotechnology industry. A consistent boost in the cultivation of biotech crops is said to be the key reason behind the growth.

Asia-Pacific is among the other, a swiftly growing region in the global market. To be specific, the Indian market is the most prominent in this segment. Japan also shows great prospects. UK and Germany are leading European nations. The most significant among others are the African and Middle East market touted to be the most promising. 

Agricultural Biotechnology Market Key Players

The Prominent Players in the Global Agricultural Biotechnology Market are Arcadia Biosciences (US)., Thermo Fisher Scientific (US), Bayer AG (Germany), Biocentury Transgene Co., Ltd (China), Vilmorin & Cie (France), Eurofins Scientific (Luxembourg), LGC Biosearch Technologies (US), Corteva Agriscience ( US), Dr. Chip Biotech Inc. (Taiwan), Evogene Ltd (Israel), and Yield10 Bioscience, Inc. (US).

Agricultural Biotechnology Industry news

Cole of Duty publishes reports on the global growth perspective of the agricultural biotechnology market. The report figures out all the crucial aspects associated with the market contributing to the market. It also identifies the key domains where the growth prospect is expected to be the most significant. It thus provides wholesome analysis on each aspect associated with the market.    

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ 

Cell Isolation Market Size, Industry Analysis, Key Findings, Share, Research And Key Findings

Market Report Titled “Cell Isolation Market Research Report – Forecast to 2023” is a Specialist Examination Report Explores the Market by Research Methodology, Segmentation, Key Players, and Major Region Globally.

Cell Isolation Market – Competitive Landscape

Highly competitive, the Cell Isolation market appears fragmented, with many well-established players churning the market competition. Due to the lack of patent protection, players invest substantially in R&D activities and clinical trials. A large market for supportive and symptomatic production exists, which is, however, saturated and facing pricing pressures. However, the research pipeline is robust, and the market is expected to react favorably for the industry players. A novel curative product will have fast market uptake with the least marketing expenditure. Prominent players competing for market space use a new product development strategy.

Read more news on:

Cell Isolation Market Major Players:

Players leading the global cell isolation market include Stemcell Technologies, GE Healthcare, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., Beckman Coulter, TERUMO Corporation, PluriSelect Life Science UG, Miltenyi Biotec, F. Hoffmann-La Roche AG, Cell Biolabs, Inc., and Sartorius AG, among others.

Cell Isolation Market Analysis

The cell isolation process is used in cell-based research, diagnosis, stem-cell research, and other applications. Over the past few years, the prevalence of myriads of chronic diseases is growing continually, which in turn, increases cancer research and stem-cell research numbers. Resultantly, the global cell isolation industry is growing at a steady rate, witnessing the huge demand for media & sera, reagents, and other products.

Moreover, increasing government funding support in cell-based research escalates the market growth to furthered height. According to Market Research Future (MRFR), the global cell isolation market is expected to garner a valuation of USD 10,567.4 MN by the end of 2023. In its recently published analysis, MRFR also asserts that the market would register a whopping 17.1% CAGR throughout the assessment period (2018-2023).

Additionally, factors such as increasing geriatric populations, rising number of patients suffering from chronic diseases, and continuous development in the technology act as major growth drivers for the market. Moreover, technological advancements, increasing application of cell isolation for regenerative medicines are boosting the market growth. Increasing research funding significantly increases the demand for cell isolation instruments.

Simultaneously, the increasing amount of funding by biotechnology companies is anticipated to contribute to the growth of the market. The development of effective disease-modifying drugs that can lower the frequency of relapses & the development of diseases propels the market demand. Furthermore, increasing awareness about the importance of cell isolation in the development of effective diagnostics techniques drives the growth of the market. 

Cell Isolation Market – Segments

The report is segmented into six dynamics;

By Product : Consumables (Media & Sera, Reagents, Kits, Beads, Disposables, others), Instruments (Centrifuges, Flow Cytometers, Magnetic-Activated Cell Separator Systems, Filtration Systems, others), and others.

By Cell Type: Human Cells and Animal Cells.

By Technique: Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation, and others.

By Application: Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, Therapeutics, and others.

By End User: Research Laboratories & Institutes, Biotechnology & Biopharmaceutical Companies, Cell Banks, Hospitals & Diagnostic Laboratories, and others.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World. 

Cell Isolation Market – Regional Analysis

North America dominates the global cell isolation market. The largest market share attributes to the increasing prevalence of myriads of chronic diseases and rising R&D investments by the public & private organizations. Besides, excellent reimbursement policies, alongside the large companies in the region, act as major growth drivers.

The US leads the cell isolation market in North America with a large patient pool suffering from cancer. Increasing numbers of cancer patients would enhance market growth during the forecasted period. The North American cell isolation market is estimated to retain its leading position in the global market throughout the forecast period.

Europe stands second in the global cell isolation market. The market is driven by a sizeable pool of cancer patients and the higher use of stem cell therapy. Moreover, factors like the rising numbers of advanced treatment facilities and growing healthcare expenditure in the region drive market growth.

Also, rising government initiatives & funding to drive R&D required for breakthrough drug discoveries for the treatment of increasing numbers of chronic diseases foster the regional market growth. The European cell isolation market is projected to hold a healthy share in the global market over the assessment period.

The Asia Pacific cell isolation market size is forecasted to generate the fastest growth owing to the availability of better diagnostic techniques. Also, factors such as the huge patient pool of chronic diseases and government initiatives of healthcare reform impact the regional market growth favourably. Besides, the rising treatment rates and intensity is expected to provide an enormous impetus to the growth of the regional market.

Additionally, significant public healthcare expenditure and excellent development of large medical centers in the region would influence the market growth. The APAC cell isolation market is anticipated to create a substantial revenue pocket over the review period.  

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Cell Isolation Industry/ Innovation/ Related News:

May 28, 2020 —- Lonza Sales AG (Switzerland) and Sanquin Reagents BV (Netherlands) announced their partnership for commercialization of specialized MAT reagents for accurate and reliable in vitro pyrogen testing. Lonza is a leading wholesale distributor of chemicals and allied products. Sanquin Reagents is a not-for-profit organization involved in a safe & efficient supply of blood and blood products in the Netherlands.

The partnership would facilitate global access to a sustainable, highly sensitive methodology for in vitro pyrogen testing essential for parenteral pharmaceuticals’ safety during development, manufacture, and release to market. 

Healthcare Artificial Intelligence (AI) Market Comprehensive Analysis, Business Opportunities, Development Strategy, Emerging Technologies, Global Trends And Forecast

This Market report “Global Healthcare Artificial Intelligence (AI) Market Research Report 2020” provides detailed insight covering all important parameters including Development Trends, Challenges, Opportunities, Key Manufacturers and Competitive Analysis.

Healthcare Artificial Intelligence (AI) Market Competitive Analysis

The expansion of a strong value chain is additionally motivating the development of the market. The vertical supplements and product tactics of the market are advancing the potential of the market players. The growth of the market is moving in a promising direction due to new product introductions or intensifying gross revenue of the players in the market. Increased conformity of market players to new customers and market trend inclinations are boosting the growth curve of the market and will persist in the forecast period. The tactical goals intended for the market are buoyed due to advantageous product differentiation carried out by market contestants. Substantial cuts in administrative costs are inducing further expansion of the market. The effective implementation of strategies is likely to stimulate the market in the coming years.

Read more News on:

The noteworthy players in the healthcare AI market are Deep Genomics, Koninklijke Philips N.V., Stryker, CloudMedx Inc., General Vision, IBM Watson Health, Google, General Electric, Next IT Corp., Intel Corporation, Microsoft Corporation, and NVIDIA Corporation.

Healthcare Artificial Intelligence (AI) Market – Overview

The rate of innovation in the healthcare sector has gathered significant momentum recently, and one of the main benefits gained is the incorporation of artificial intelligence in healthcare services. Market reports connected with the healthcare IT industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The Artificial Intelligence (AI) in Healthcare Market statistics  is projected to achieve a CAGR of 51.9% in the course of the forecast period.

The streamlining of healthcare data which comprises of structured and unstructured data is boosting the growth of the healthcare artificial intelligence market. The application of AI to a wide range of healthcare related research purposes is transforming the growth potential of the market. The healthcare artificial intelligence is expected to create new prospects for growth due to its benefits in reducing the dependence on trained professionals who are in shortage in the market.

Healthcare Artificial Intelligence (AI) Market Segmental Analysis

The segmental analysis of the healthcare artificial intelligence market is carried out on the basis of technology, component, application, end-user, and region. The component-based segment of the healthcare AI comprises of hardware, software, and services. The segmentation on the basis of applications for the healthcare AI market comprises of robot-assisted surgery, virtual nursing assistant, dosage error reduction, preliminary diagnosis, clinical trial, and automated image diagnosis. On the basis of technology, the healthcare AI segment market is segmented into machine learning, querying method, natural language processing, and others. The end users segment of the healthcare AI market consists of academic & research laboratories, pharmaceutical & biotechnology companies, and hospitals & diagnostic centers.

Healthcare Artificial Intelligence (AI) Market Detailed Regional Analysis

The regional analysis of the healthcare AI market report comprises of regions such as Europe, Asia Pacific, the Middle East, the Americas, Africa. The Americas region has the principal share of the market which is expected to be maintained over the forecast period. The advanced countries such as the U.S are heading the development for the regional market owing to the incidence of a sophisticated healthcare sector. The rising biotechnology industry and the growing uses of robot-assisted surgery are among the important factors that have put the Americas region in a leadership position. The European region accounts for the next chief market owing to the continuing R&D activities undertaken in the region for healthcare AI. The region has a comparable growth pattern to the Americas, and the swift adoption of AI in healthcare is inspiring market growth in the region. The Asia Pacific region is a swiftly growing market due to a huge patient population which is progressively placing demand for good quality therapeutic care for chronic diseases. The Middle East and African region will show gradual development compared to other regions due to the absence of advanced healthcare services in the majority of the region. The developing economies in the MEA region are expected to have a major impact on the market’s growth.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Cell Therapy Market Estimated To Grow With A Healthy CAGR During Forecast Period

The report gives detail analysis of the “Cell Therapy Market” structure along with forecast, market size & share, different segments and developing trends of the industry.

Cell Therapy Market Overview

The growing demands for new treatment methods and rising cases of chronic disease have led the researchers to look for new outlooks with cell therapy. This method has emerged as the pit stop in the medical industry for the treatment of complex medical conditions. The cell therapy products are made from stem cells and are inserted into the patient’s body. On observing the current market trends, the global cell therapy market is projected to grow at a 22 % annual rate during the survey period. The cell therapy market is powered by growing geriatric population counts, increasing awareness, and extensive adoption of this technology.

Read more news on:

The cell therapy works on the primary part of life that is a cell for the treatment and prevention of chronic conditions and has come out as a lifesaving practice. This technique is also helpful in manufacturing regenerative medicines helpful in restoration of organ functioning while maintaining & improving the operation. The researchers now prefer the human cells above animal cells, which is one of the major factors driving this market.

Cell therapy has come out more robust with time, but the factors like high overall costs and low success rates are damaging the market’s growth. The companies are collaborating with government authorities and other research firms to get faster results in research & development of the new technologies and methods.

Cell Therapy Market segments

The global cell therapy market Size is segmented into four parts mentioned below:

Cell types: For cell therapy, stem cells (bone marrow, umbilical cord, blood, and others) and non-stem cells are used.

Types of therapies: Allogeneic and autologous therapies are available presently.

Therapeutic: It is used in the diagnosis of dermatology, musculoskeletal disorders, autoimmune and other disorders.

End-Users: Major healthcare facilities like hospitals, clinics, research institutes, and others are using this technique.

Cell Therapy Market Regional Summary

America, Europe, Asia Pacific, and The Middle East & Africa are the major regions observed for the global cell therapy market.

The American region is the market leader in the present era and will maintain its lead during the survey period, with the North American region, the major shareholder. Advanced healthcare facilities, rising disease counts, presence of major companies, and other factors are driving the market here. The European region is the next biggest market due to increasing investments in research & development programs, raising awareness, governmental initiatives, and other factors.

The Asia Pacific region is the next market in this race but will emerge as the fastest growing market in this period. Developing healthcare structures, rise in related budgets, increasing awareness, large population covers, and other factors are driving the market in this region.

The rest of the regions are still struggling in this field due to weak economic structures and relatively less awareness.

Cell Therapy Market Key Players

The prominent players in the global cell therapy market are Mesoblast Ltd, Vericel Corporation, Osiris Therapeutics, Inc, JCR Pharmaceuticals Co., Ltd, NuVasive, Inc., Pharmicell Co., Ltd, RTI Surgical Holdings, Inc., AlloSource, Holostem Terapie Avanzate S.r.l., Medipost Co., Ltd

The players operating in the global cell therapy market are focusing on product launches, along with expanding their global footprints by entering untapped markets.

Cell Therapy Industry News

The global cell therapy market is gaining a desirable response from all over the world due to seamless opportunities, but factors like high costs and low success rates are restraining the growth rates. The American region is currently leading the market with the North American region, the major shareholder, whereas the Asia Pacific region, will file the highest growth rate during the survey period.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Healthcare Electronic Data Interchange Market Size, Industry Analysis, Key Findings, Share, Development Status, Emerging Technologies And Key Findings

Market Research Future has declared the expansion of the “Worldwide Healthcare Electronic Data Interchange Market Research Report which gives Market Size, Shares and Forecasts till 2023.

Healthcare Electronic Data Interchange Market Scope

The global healthcare electronic data interchange market 2020 logged 8.8% CAGR rise during the forecast period 2018–2023, as per the study conducted by Market Research Future. The profit of the Healthcare Electronic Data Interchange Market is observed in the part where a lift in revenue occurred after the year 2017 when the market gained worth USD 2674 million in revenue.

Healthcare Electronic Data Interchange Market: Overview

Healthcare electronic data interchange (EDI) is generally defined as a structured method to transmit healthcare data between computer and data management systems.

Over the year, electronic data interchange has witnessed a sharp rise in their use, which directs towards assisting in keeping costs of healthcare facilities at an affordable level, improving the quality of healthcare delivery, supporting the healthcare process, and making the services accurate, fast, reliable, and secure. The electronic data interchange further has gained a lot of traction due to its assistance in minimizing various kinds of time-consuming processes and streamlines the claim management processes.

Read more news on:

To support the market for healthcare electronic data interchange and its growth, the market achieved a lot of prominences. In the case of point, in 2010, the ObamaCare Act (the Affordable Care Act) was passed in the U.S., mandating the use of enrolled or dis-enrolled transactions between the payers and providers in the U.S. Also, the implementation of favorable policy such as Health Insurance Portability & Accountability Act (HIPAA). This was to provide data privacy and security provisions to protect medical information.

Many recent government initiatives of developed, as well as emerging countries worldwide, are supporting healthcare that results in wide adopting EDI systems are the prevalent drivers of the healthcare EDI market. The management, processing, and transfer of the healthcare data, including as medication, patient credentials, diagnostic data, and emergency service records are kept private with the help of electronic data interchange, which has made it demand to the highest level in the emerging healthcare centers. However, concerning digitalization, EDI has helped to manage a considerable amount of data in a systematic, efficient, and accessible manner.

Top Market Drivers & Key Challenges

The global market of healthcare electronic data interchange is presumed to gain traction over the years leading to the advent of big data analytics, the initiatives and incentive programs by different organizations to promote healthcare IT, and favorable policy implementation. The implementation of these has eventually taken the market to earn more valuation in the forecast period. On the other side, EDI healthcare transactions are getting traction by the elimination of all paper trails and digitization of transactions, which is resulting in lower handling costs of processing healthcare documents. Therefore, based on the Workgroup for Electronic Data Interchange (WEDI) estimations, healthcare players can now easily create significant savings of USD 1 per claim for health plans, USD 1.49 for physicians, USD 0.86 for hospitals, and USD 0.83 for others by implementing EDI.

At the same time, a surge in the number of end-users such as providers, payers, pharmaceutical & medical device industries are equally anticipated to fuel the demand of the EDI services or solutions. The EDI services or solutions are enjoying massive demand as healthcare payers are highly making use of EDI for the evaluation of insurance claims before their payment settlement, prevention & detection of fraudulent claims. This advantage is helping the market to expand its worth in the foreseeable years.

Further key findings from the study suggest that the snowballing number of end-users are probable to force the demand for the global healthcare electronic data interchange market over the assessment period. Massive influx of investments is also coming from giant pharmaceutical industries and medical device manufacturers who are adopting electronic data interchange services or solutions into their process due to growing competitiveness, pricing pressure, and lower profit margins. Given this advantage, the market from here is also anticipated to assist in the growth in the coming years

On the contrary, the factor of high implementation cost of EDI software, hesitancy to switch from conventional methods, and data security might hinder the global healthcare electronic data interchange (EDI) market trends over the forecast period.

Healthcare Electronic Data Interchange Market Segmentation

The global healthcare electronic data interchange market has been analyzed based on segmental analysis, which includes component, delivery mode, transaction, and end-user.

The component segment of the market includes software and services.

The delivery mode segment of the market includes direct (Point-to-Point) EDI, EDI value-added network (VAN), cloud-based EDI, and mobile EDI.

The transaction segment of the market includes claim attachments, eligibility inquiry and response, claims & encounters and payment & remittance advance, referral certification and authorization claim status and response, enrollments.

The end-user segment of the market includes pharmaceutical & medical device industries, healthcare providers, healthcare payers, and others. Wherein, the healthcare payers segment has the possibility to occupy the largest market share in support of increasing adoption of EDI for financial management by physicians and clinicians. Even the pharmaceutical & medical device industries are likely to expand at the highest CAGR with the growing demand for insurance plans.

Healthcare Electronic Data Interchange Market Regional Framework

The global healthcare electronic data interchange market has been further studied among the critical regions of the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

As per the study conducted, the region of the Americas has a promising future in terms of leading the global healthcare electronic data interchange (EDI) market. The reason behind its leadership is due to the rising healthcare expenditure, active participation of market players, and technological advancements in EDI software. In the case of point, back in 2016, PLEXIS Healthcare Systems publicized the development of its EDI services with the formal launch of Ignite EDI. The Ignite EDI hub is powered by four smart, foundational building blocks, i.e., the EDI gateway, the Atlas engine, portal technologies, and EDI exploration services.

The market of EDI in the region of Europe can also become the second most expanding market in the global healthcare electronic data interchange (EDI) market. Such an expansion of the market growth in this region is credited to the government funding and favorable policy implementation.

The healthcare electronic data interchange market in Asia-Pacific, most of the key players, are making high investments, especially from the countries such as China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Due to this reason, the Asia-Pacific region can become the fastest-growing region. Escalating spending on information technology in the Asia-Pacific region has also given the market a substantial push resulting in a great expansion that will continue to the forecast period as well. Claiming to the data suggested by the India Brand Equity Foundation (IBEF), expenditure in information technology in India might grow by over 9 percent to reach USD 87.1 billion in the coming years.

In the last comes the market in the Middle East & Africa, which is also likely to occupy the least share of the market in support of raising awareness about healthcare electronic data interchange (EDI) software.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Healthcare Electronic Data Interchange Market Key Players

GE Healthcare, Cognizant, Passport Health Communications, McKesson Corporation, Siemens Healthineers, Allscripts Healthcare Solutions Inc., Optum, Inc., Schreiner Group, The SSI Group, LLC, Experian Information Solutions, Inc., Emdeon Inc., ZirMed Inc., HealthFusion are the top major market players known for their high investments making the market more profitable.

Organic and Natural Tampons Market 2020 Overview, Segmentation, Application, Technology, Industry Challenges, Drivers, Trends And Forecast To 2023

Market Report Titled “Organic and Natural Tampons Market Research Report – Forecast to 2023” is a Specialist Examination Report Explores the Market by Research Methodology, Segmentation, Key Players, and Major Region Globally.

Organic and Natural Tampons Market Analysis

The global organic and natural tampons market is expected to exhibit a solid 8.67% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The organic and natural tampons was valued at USD 590.6 million in 2017 and is likely to exhibit steady, stable growth over the forecast period.

Organic and natural tampons are becoming widely popular due to the growing demand for natural products in the feminine hygiene sector and the growing product diversification in the field of feminine hygiene products. Due to the growing demand from the demographic of working women, feminine hygiene product manufacturers are looking to provide a widespread choice to their female consumers in terms of product configuration. This has become a major driver for the organic and natural tampons market due to the growing demand for organic and natural products in the healthcare sector. The rising demand for organic and natural products is mainly driven by the increasing perception that organic and natural products are better for the consumer than conventional artificial products. This is likely to be a major driver for the global organic and natural tampons market over the forecast period.

Read more news on:

The growing demographic of working women around the world is likely to be a major driver for the global organic and natural tampons market over the forecast period. In recent years, due to female empowerment, the number of working women has grown rapidly. This has driven the demand for sophisticated feminine hygiene products such as sanitary napkins and tampons. Tampons have become widely popular as a feminine hygiene product due to their convenience, which makes them highly popular among working women, who need sleek, easy to use solutions for use during periods. This is likely to be a major driver for the global organic and natural tampons market over the forecast period.

Organic and Natural Tampons Market Competitive Leaderboard:

Leading players in the global organic and natural tampons market include NutraMarks, TOM Organic, Maxim Hygiene, The Honest Company, Seventh Generation, BON, ALYK, Bodywise, and Procter & Gamble. Leading players in the global organic and natural tampons market are likely to focus on product capacity expansion and product diversification over the coming years, as the demand for various types of tampons is likely to grow over the forecast period.

Organic and Natural Tampons Market Segmentation:

The global organic and natural tampons market trends has been segmented into type, size, odor type, and region.

Based on type, the organic and natural tampons market is segmented into cardboard applicator, plastic applicator, digital tampon, and others.

Based on size, the organic and natural tampons market is segmented into junior tampons, regular tampons, super tampons, and super-plus tampons. The regular tampons segment is expected to account for the largest share segment of the market in 2023, as it was the largest segment in 2017 and is likely to experience steady growth over the forecast period. The majority of women prefer regular tampons, leading to a growing demand for the segment.

Based on odor type, the organic and natural tampons market is segmented into fragrance based and non-fragrance based. The non-fragrance-based segment is expected to account for the largest share segment of the market in 2017. Fragrance-based tampons are a relatively novel part of the organic and natural tampons market and are likely to be a major segment in the long-term future. However, in the short to medium term, conventional non-fragrance-based tampons are likely to dominate the global organic and natural tampons market.

Organic and Natural Tampons Market Regional Analysis:

The Americas is expected to dominate the global organic and natural tampons market over the forecast period, while Asia Pacific is expected to be the fastest growing regional market over the forecast period. The growing number of working women in North America is the major driver for the organic and natural tampons market in the region. The high market volume in Asia Pacific is likely to make it an important regional market for organic and natural tampons over the forecast period.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Augmented Reality in Healthcare Market Competition, Growth, Latest Innovations And Research Report

Augmented Reality in Healthcare Market 2020 Global Industry Analysis To 2023, is latest research report on Global Airway Management Industry Size, Share, Trends, Growth, And Regional Forecast.

Augmented Reality in Healthcare Market Insight

Augmented Reality (AR) is a technology that redefines the space and adds a virtual covering or layer over objects with complete geographic specificity. It digitalizes your surroundings by creating virtual content in the real world. The disruptive technology has positively impacted various industries and boasts massive potential for other industries as well. One such industry where AR is rapidly spreading and creating ripples of impact is healthcare, a sector that is always willing to implement or adopt new technologies to further enhance its productivity and efficacy level.

The expanding population pool and rising demand for more surgical treatments coupled with the increasing expenditure in the healthcare sector are all contributing to the market’s growth. The market is also boosted by penetration of connected devices in the healthcare industry and the number of investments in augmented reality by private and government organizations to make numerous devices that are handheld, head-mounted displays, and others

Read more news on:

Market Research Future estimates that the global augmented reality in healthcare market trends to reach a valuation of 1.32 billion by 2023 at an impressive CAGR of 23%. The growing importance directed towards augmented reality alongside artificial intelligence is expected to be a driving factor behind the growth of the market. The growing adoption of mobile AR technology is further pushing the market expansion. The mobile AR technology helps bridge the gap between patient and the healthcare provider and builds their relationship. The applications help educate the patient and provide them with valuable information to help them make better decisions about their own health.

Augmented Reality in Healthcare Market Segmentation

The global augmented reality in the healthcare market has been segmented on the basis of device type, application, and component.

By component, the market includes software, hardware, and others. The hardware segment is narrowed down into displays and projectors, cameras, sensors, position tracker, sensors, and others.

By device type, the market includes handheld device, head-mounted display, and others.

By application, the market comprises medical training and education, fitness management, and others.

Augmented Reality in Healthcare Market Regional Analysis

The regional segmentation of the augmented reality in the healthcare market growth covers regions like Europe, Asia-Pacific, North America, and the Rest of the World.

North America tops the regional standings in terms of market share. Increasing adoption and usage of consumer electronic devices is expanding the demand for AR in this region. The influence of augmented reality in the healthcare sector will drive the market towards further growth and expansion in the forthcoming years. The regional market in Europe is projected to experience rapid-paced growth during the assessment period between 2017-2023. In the Asia-Pacific region, economically strong powerhouses like India, China, and Japan, will contribute significantly to the overall growth of the market. Herein, the region is expected to grow with the highest CAGR over the review period.

Augmented Reality in Healthcare Market Competitive Analysis

The global augmented reality in the healthcare market is home to a number of noteworthy players. Players who are adding new strategies and coming up with new innovations to drive the progress of the market. Key players in the market include Osterhout Design Group (U.S.), Mindmaze (Switzerland), DAQRI (U.S.), Medical Realities (U.K), Microsoft Corporation (U.S.), Wikitude GmbH (Austria), 3D Systems (U.S.), CAE Healthcare (U.S.), Google LLC. (U.S.), Augmedix (U.S.), Philips Healthcare (Netherlands & U.S.), Siemens Healthineers (Germany), VirtaMed (Switzerland), Oculus VR (U.S.), Magic Leap, Inc. (U.S.), Blippar (U.K), HTC (Taiwan), Atheer (U.S.), and Virtually Better (U.S.) among others.

Augmented Reality in Healthcare Insustry News

On 14th Feb 2019, Medivis, a medical imaging and visualization organization, announced the introduction of SurgicalAR, a one-of-a-kind AR technology platform for surgical applications. The platform promises to allow physicians to overlay images directly on the patient, thereby allowing for unmatched precision and real-time decision-making capability.

On 26th Feb 2019, Royal Philips, a globally renowned health tech company, revealed at the MWC Barcelona a unique augmented reality concept that they have developed in collaboration with Microsoft for image-guided minimally invasive surgeries.

 Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Create your website at
Get started